Showing results (2351-2360 of 5,178) with videos related to
Sort By:
Pageof 518
Metallomics : Integrated Biometal Science|March 11, 2021
Biochemical impact of a disease-causing Ile67Asn substitution on BOLA3 proteinSambuddha Sen, Zechariah Thompson, Christine Wachnowsky, et al.Current Hypertension Reports|October 27, 2018
Out of Office Blood Pressure Measurement in Pregnancy and the Postpartum PeriodNatalie A Bello, Eliza Miller, Kirsten Cleary, et al.Journal of Autism and Developmental Disorders|April 20, 2024
Investigating Parental Observations of Early Autism Development in Simplex and Multiplex FamiliesDominique B Cleary, Murray T Maybery, Hannah Waddington, et al.Health Policy and Planning|September 19, 2015
Does treatment collection and observation each day keep the patient away? An analysis of the determinants of adherence among patients with Tuberculosis in South AfricaStephen Birch, Veloshnee Govender, Jana Fried, et al.Pharmacology, Biochemistry, and Behavior|February 1, 1989
Molindone: effects in pigeons responding under conditional discrimination tasksM J Picker, J P Cleary, K Berens, et al.Early Intervention in Psychiatry|October 21, 2017
Factor structure of the Cannabis Experiences Questionnaire in a first-episode psychosis sampleMichael L Birnbaum, Sean D Cleary, Claire Ramsay Wan, et al.Health & Place|September 15, 2019
Changes in perceptions of urban green space are related to changes in psychological well-being: Cross-sectional and longitudinal study of mid-aged urban residentsAnne Cleary, Anne Roiko, Nicola W Burton, et al.International Journal of Clinical Pharmacology and Therapeutics|July 11, 1998
Zolmitriptan (311C90) does not interact with fluoxetine in healthy volunteersD A Smith, E W Cleary, S Watkins, et al.Proceedings. IEEE Computational Systems Bioinformatics Conference|February 2, 2006
AZuRE, a scalable system for automated term disambiguation of gene and protein namesRaf M Podowski, John G Cleary, Nicholas T Goncharoff, et al.Clinical Genetics|June 17, 2008
Isolated growth hormone deficiency type II caused by a point mutation that alters both splice site strength and splicing enhancer functionN Shariat, C D Holladay, R K Cleary, et al.Pageof 518